Dcpp3 Inhibitors
Dcpp3 inhibitors are a class of chemical compounds designed to target the Dcpp3 protein, also known as "Dipeptidyl Carboxypeptidase 3." This enzyme belongs to the broader family of metallopeptidases, which are enzymes that catalyze the hydrolysis of peptide bonds in proteins, typically using a metal ion such as zinc at their active site. Dcpp3 is involved in the sequential cleavage of dipeptides from the carboxyl end of protein substrates, regulating the maturation or degradation of peptides. Metallopeptidases like Dcpp3 play crucial roles in protein turnover, processing, and regulation, influencing a variety of biochemical pathways related to peptide signaling, protein activation, and intracellular protein degradation.
Inhibitors of Dcpp3 function by binding to the active site of the enzyme, usually in close proximity to the metal ion, thereby blocking its ability to cleave peptide bonds. These inhibitors are valuable tools for studying the mechanistic aspects of protein degradation and processing, as well as for exploring how Dcpp3 interacts with its substrates and other proteins in various biological systems. By inhibiting Dcpp3's activity, researchers can examine the enzyme's role in maintaining cellular protein homeostasis and how this balance affects broader cellular functions. Additionally, Dcpp3 inhibitors allow scientists to explore how metallopeptidase activity influences peptide regulation and protein lifespan, providing insight into the enzyme's specific contributions to protein dynamics and molecular stability within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Irreversible PI3K inhibitor that directly blocks the PI3K/Akt pathway. By inhibiting PI3K, it disrupts Akt phosphorylation, indirectly hindering Dcpp3 activation associated with this signaling cascade. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Blocks NF-κB activation by inhibiting IκB phosphorylation. Indirectly modulates Dcpp3 by interfering with NF-κB signaling. The inhibition of NF-κB alters the transcriptional regulation of Dcpp3, influencing its activity. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK1/2 inhibitor blocking cytokine-induced signal transduction. Indirectly interferes with Dcpp3 by suppressing JAK activity. The inhibition of JAK disrupts the cytokine-mediated pathways essential for the gene's function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Broad-spectrum PKC inhibitor. Indirectly hinders Dcpp3 function by blocking PKC activation within the Dcpp3 signaling cascade. The inhibition of PKC disrupts the downstream events crucial for the gene's involvement. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that directly modulates cytoskeletal dynamics linked to Dcpp3 signaling. By suppressing ROCK activity, it indirectly interferes with Dcpp3, disrupting the cytoskeletal events crucial for the gene's function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective PDE4 inhibitor affecting cyclic nucleotide levels in the Dcpp3-associated pathway. Indirectly influences Dcpp3 by disrupting PDE activity. The inhibition of PDE alters the intracellular signaling crucial for the gene's activity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor that directly hinders Dcpp3 function. By suppressing GSK-3 activity, it disrupts the downstream events crucial for the gene's involvement within the Dcpp3 signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that directly disrupts the Dcpp3-associated signaling pathway. By blocking JNK activity, it indirectly interferes with Dcpp3 function, affecting the downstream events crucial for the gene's involvement. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dual SFK/Abl kinase inhibitor. Indirectly interferes with Dcpp3-associated signaling. The inhibition of SFK disrupts Dcpp3 function by affecting the downstream events crucial for the gene's involvement. | ||||||